Performance Evaluation of the NaviAid™ G-Eye System

This study is currently recruiting participants.
Verified November 2012 by Smart Medical Systems Ltd.
Sponsor:
Information provided by (Responsible Party):
Smart Medical Systems Ltd.
ClinicalTrials.gov Identifier:
NCT01552200
First received: March 6, 2012
Last updated: November 11, 2012
Last verified: November 2012

March 6, 2012
November 11, 2012
June 2012
December 2012   (final data collection date for primary outcome measure)
The purpose of this study is to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure. [ Time Frame: Subjects will be followed during the study period (approximatly 3 hours) and follow up will be done within 48-72 hours following the procedure ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01552200 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Performance Evaluation of the NaviAid™ G-Eye System
Performance Evaluation of the NaviAid™ G-Eye System

The purpose of this study is to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure.

Colonoscopy is the gold-standard method for CRC screening, as it enables detection and real-time removal of pre-cancerous polyps during the examination. It is well known that lesions are missed during routine colonoscopy.5 major reasons can be detailed for missing polyps during colonoscopy: polyps that are hidden behind folds, polyps that are masked by the colon's topography and natural folds, shallow polyps, unscreened portions of the colon (due to incomplete colonoscopy) and endoscope slippage. The NaviAid™ G-Eye system presents a unique concept that overcomes all 5 items listed above, providing an overall solution to the two endoscopy key challenges of limited detection/treatment yield and limited operation range.

The G-Eye endoscope comprises a standard endoscope onto which a unique balloon is permanently integrated, at its bending section. The NaviAid™ G-Eye may be used for performing controlled withdrawal and endoscope stabilization.

A major attribute of the NaviAid™ G-Eye system controlled withdrawal technique of the endoscope, with the balloon moderately inflated is to expand and stretch the intestinal lumen during endoscope withdrawal.

This is a multicenter, two-arm, randomized, open-label study intended to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure.

Subjects will be randomized to one of two groups: Group A, the "Study Group," and Group B, the "Control Group."

Group A: Subjects will undergo a complete standard colonoscopy as the first procedure. Immediately after the standard colonoscopy procedure, a complete NaviAid™ G-Eye procedure will be performed by the same endoscopist.

Group B: Subjects will undergo a complete NaviAid™ G-Eye procedure as the first procedure. Immediately after the NaviAid™ G-Eye procedure, a complete standard colonoscopy will be performed by the same endoscopist.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Diagnostic
  • Colorectal Cancer
  • Polyp
  • Adenoma
  • Procedure: Group A-Standard Colonoscopy, then NaviAid™ G-Eye procedure
    Standard Colonoscopy,NaviAid™ G-Eye procedure
  • Procedure: Group B-NaviAid™ G-Eye procedure, then Standard Colonoscopy
    G-Eye procedure, Standard Colonoscopy
  • Experimental: A-Standard Colonoscopy, G-Eye procedure
    Standard Colonoscopy,G-Eye procedure
    Intervention: Procedure: Group A-Standard Colonoscopy, then NaviAid™ G-Eye procedure
  • Active Comparator: B- G-Eye procedure, Standard Colonoscopy
    G-Eye procedure,Standard Colonoscopy
    Intervention: Procedure: Group B-NaviAid™ G-Eye procedure, then Standard Colonoscopy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
126
April 2013
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
  • The patient is over 40 years old;
  • The patient must understand and provide written consent for the procedure.

Exclusion Criteria:

  • Subjects with inflammatory bowel disease;
  • Subjects with a personal history of polyposis syndrome;
  • Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
  • Subjects with diverticulitis or toxic megacolon;
  • Subjects with a history of radiation therapy to abdomen or pelvis;
  • Pregnant or lactating female subjects;
  • Subjects who are currently enrolled in another clinical investigation.
  • Subjects with routine oral or parenteral use of anticoagulants
  • Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
  • Any patient condition deemed too risky for the study by the investigator
Both
40 Years and older
Yes
Not Provided
Israel
 
NCT01552200
G-Eye 15501
No
Smart Medical Systems Ltd.
Smart Medical Systems Ltd.
Not Provided
Principal Investigator: Erwin Santo, MD Tel-Aviv Sourasky Medical Center
Principal Investigator: Beny Shpak, MD Laniado Hospital
Principal Investigator: Yael Kopelman, MD Hadassah Medical Organization
Smart Medical Systems Ltd.
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP